FHIT gene mutations and single nucleotide polymorphism in Indian oral and cervical squamous cell carcinomas.

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  N. Tsuchida,et al.  The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India. , 1998, Gynecologic oncology.

[3]  T. Enomoto,et al.  Aberrant FHIT transcripts in squamous cell carcinoma of the uterine cervix , 1998, International journal of cancer.

[4]  J. Minna,et al.  Abnormalities of fragile histidine triad genomic and complementary DNAs in cervical cancer: association with human papillomavirus type. , 1998, Journal of the National Cancer Institute.

[5]  C. Shen,et al.  HPV‐associated cervical cancers show frequent allelic loss at 3p14 but no apparent aberration of FHIT mRNA , 1998, International journal of cancer.

[6]  F P Perera,et al.  Environment and cancer: who are susceptible? , 1997, Science.

[7]  F. Mitelman,et al.  Variable FHIT transcripts in non‐neoplastic tissues , 1997 .

[8]  G. Giaccone,et al.  FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. , 1997, Cancer research.

[9]  A. Marchetti,et al.  Association between cigarette smoking and FHIT gene alterations in lung cancer. , 1997, Cancer research.

[10]  M. Birrer,et al.  FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines. , 1997, Cancer research.

[11]  M. Kurosumi,et al.  Abnormal FHIT transcripts in human breast carcinomas: a clinicopathological and epidemiological analysis of 61 Japanese cases. , 1997, Cancer research.

[12]  C. Harris,et al.  FHIT mutations in human primary gastric cancer. , 1997, Cancer research.

[13]  C. Croce,et al.  Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene. , 1997, Cancer research.

[14]  C. Croce,et al.  Structure and expression of the human FHIT gene in normal and tumor cells. , 1997, Cancer research.

[15]  K. Yanagisawa,et al.  Molecular analysis of the FHIT gene at 3p14.2 in lung cancer cell lines. , 1996, Cancer research.

[16]  R. Lotan,et al.  Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines. , 1996, Cancer research.

[17]  L. D. Barnes,et al.  Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5"'-P1,P3-triphosphate hydrolase. , 1996, Biochemistry.

[18]  C. Croce,et al.  FHIT gene alterations in head and neck squamous cell carcinomas. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. Croce,et al.  The FHIT gene at 3p14.2 is abnormal in breast carcinomas. , 1996, Cancer research.

[20]  M. Wigler,et al.  Evaluation of the FHIT gene in colorectal cancers. , 1996, Cancer research.

[21]  C. Croce,et al.  The FHIT Gene at 3p14.2 Is Abnormal in Lung Cancer , 1996, Cell.

[22]  C. Croce,et al.  The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal Carcinoma–Associated t(3;8) Breakpoint, Is Abnormal in Digestive Tract Cancers , 1996, Cell.

[23]  T. Glover,et al.  FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. , 1996, Human molecular genetics.

[24]  Philip Cole,et al.  Tobacco-related mortality , 1994, Nature.

[25]  T. Kunkel.  Slippery DNA and diseases , 1993, Nature.

[26]  T. Sekiya,et al.  Allele-specific polymerase chain reaction: a method for amplification and sequence determination of a single component among a mixture of sequence variants. , 1991, Analytical biochemistry.

[27]  M. Ashburner.  A Laboratory manual , 1989 .

[28]  J. DiPaolo,et al.  Integration sites of human papillomavirus 18 DNA sequences on HeLa cell chromosomes. , 1987, Cytogenetics and cell genetics.